Tempsens IPO: 104% Gain Expected, Outshining Augmont

Tempsens Instruments (India) Ltd. is projected for a substantial 104.33% listing gain, based on its current Grey Market Premium (GMP). This potential performance significantly outpaces Augmont Enterprises, which is eyeing a 48.22% gain from its own mainboard IPO.

Tempsens Instruments Leads Listing Projections

The implied listing price for Tempsens Instruments stands at Rs 613, a direct result of its Rs 313 GMP against an upper price band of Rs 300. The Rs 650 crore IPO saw strong investor interest.

• GMP: Rs 313
• Upper Price Band: Rs 300
• Implied Listing Price: Rs 613
• Total IPO Value: Rs 650 crore
• Subscription (Aug 24, 11:00 a.m.): 44.48 times

The IPO includes a fresh issue of 32 lakh shares, valued at Rs 95 crore, alongside an offer for sale of 1.85 crore shares, amounting to Rs 555 crore. Bidding for Tempsens Instruments concluded on August 24, with allotment anticipated for August 25 and a tentative listing on August 28 across NSE and BSE.

Augmont Enterprises’ IPO Outlook

Augmont Enterprises’ IPO, valued at Rs 825 crore, suggests an implied listing price of Rs 1168. This calculation stems from its Rs 380 GMP compared to an upper price band of Rs 788. Its subscription levels were more moderate.

• GMP: Rs 380
• Upper Price Band: Rs 788
• Implied Listing Price: Rs 1168
• Total IPO Value: Rs 825 crore
• Subscription (Aug 24, 11:00 a.m.): 5.84 times

This IPO consists of a fresh issue of 79 lakh shares, worth Rs 620 crore, and an offer for sale of 26 lakh shares, totaling Rs 205 crore. Bidding for Augmont Enterprises closes on August 25, with allotment expected on August 27 and a tentative listing on August 31 on NSE and BSE.

While Tempsens Instruments currently indicates a stronger listing upside based on unofficial grey market activity, investors should remember that GMP is not a guaranteed predictor. Fluctuations are common, and consulting financial advisors before making investment decisions is advised.